"Qichensheng" completed several hundred million yuan of pre-A + round financing
Qichensheng has recently completed several hundred million yuan of pre-A + round financing. The current round of financing is led by the CICC Qide innovative biomedical equity investment fund of CICC capital, and the original shareholder sunshine capital continues to invest. The funds raised will be used to support the phase I clinical study of qichensheng's self-developed mRNA vaccine to be launched within this year. Founded at the end of 2015 and headquartered in Yizhuang, Beijing, Qichen is a biopharmaceutical company focusing on the technological innovation and R & D of mRNA, nucleic acid, cellular drugs and related industrial chain.
This text is a result of machine translation.
Related companies：
Briefing Updated 7 mins ago
· Financials
Volkswagen Tianjin parts factory resumes partial production
In depth
Jun 29, 2021 11:48 PM
May 03, 2021 09:18 AM
Apr 22, 2021 03:11 PM
Jan 28, 2021 01:11 PM
Briefing Oct 23, 2021 09:18 AM
· Technology
The software evaluation center of China automobile center has reached chip certification cooperation with Ziguang Guowei
In depth
Briefing Sep 13, 2021 10:05 AM
Semiconductor chip stocks fell in early trading
Insight
Briefing Aug 29, 2021 02:21 PM
· Technology
Ziguang Guowei: the innovative product super SIM card has realized small batch shipment
See more
Read next
In depth
Financials
Beijing Stock Exchange: A New Playground for China's Rapidly Growing SMEs
Jan 11, 2022 04:53 PM
Insight
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.